Literature DB >> 31685471

Emergence of Resistance to Novel β-Lactam-β-Lactamase Inhibitor Combinations Due to Horizontally Acquired AmpC (FOX-4) in Pseudomonas aeruginosa Sequence Type 308.

Pablo A Fraile-Ribot1, Cristóbal Del Rosario-Quintana2, Carla López-Causapé1, María A Gomis-Font1, Mar Ojeda-Vargas2, Antonio Oliver3.   

Abstract

Entities:  

Keywords:  AmpC; FOX-4; Pseudomonas aeruginosazzm321990; ceftazidime-avibactam; ceftolozane-tazobactam

Mesh：

Substances：

Year:  2019        PMID： 31685471      PMCID： PMC7187601          DOI： 10.1128/AAC.02112-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  16 in total

1.  Deciphering the Resistome of the Widespread Pseudomonas aeruginosa Sequence Type 175 International High-Risk Clone through Whole-Genome Sequencing.

Authors:  Gabriel Cabot; Carla López-Causapé; Alain A Ocampo-Sosa; Lea M Sommer; María Ángeles Domínguez; Laura Zamorano; Carlos Juan; Fe Tubau; Cristina Rodríguez; Bartolomé Moyà; Carmen Peña; Luis Martínez-Martínez; Patrick Plesiat; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

2.  Pseudomonas aeruginosa ceftolozane-tazobactam resistance development requires multiple mutations leading to overexpression and structural modification of AmpC.

Authors:  Gabriel Cabot; Sebastian Bruchmann; Xavier Mulet; Laura Zamorano; Bartolomé Moyà; Carlos Juan; Susanne Haussler; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2014-03-17       Impact factor: 5.191

3.  Mechanisms leading to in vivo ceftolozane/tazobactam resistance development during the treatment of infections caused by MDR Pseudomonas aeruginosa.

Authors:  Pablo A Fraile-Ribot; Gabriel Cabot; Xavier Mulet; Leonor Periañez; M Luisa Martín-Pena; Carlos Juan; José L Pérez; Antonio Oliver
Journal:  J Antimicrob Chemother       Date:  2018-03-01       Impact factor: 5.790

4.  plasmidSPAdes: assembling plasmids from whole genome sequencing data.

Authors:  Dmitry Antipov; Nolan Hartwick; Max Shen; Mikhail Raiko; Alla Lapidus; Pavel A Pevzner
Journal:  Bioinformatics       Date:  2016-07-27       Impact factor: 6.937

5.  Acquisition of class C β-lactamase PAC-1 by ST664 strains of Pseudomonas aeruginosa.

Authors:  Maxime Bour; Damien Fournier; Thomas Jové; Armelle Pouzol; Guillaume Miltgen; Frédéric Janvier; Katy Jeannot; Patrick Plésiat
Journal:  Antimicrob Agents Chemother       Date:  2019-09-16       Impact factor: 5.191

6.  Activity of a new cephalosporin, CXA-101 (FR264205), against beta-lactam-resistant Pseudomonas aeruginosa mutants selected in vitro and after antipseudomonal treatment of intensive care unit patients.

Authors:  Bartolome Moya; Laura Zamorano; Carlos Juan; José L Pérez; Yigong Ge; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

7.  Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clones.

Authors:  Gabriel Cabot; Alain A Ocampo-Sosa; M Angeles Domínguez; Juan F Gago; Carlos Juan; Fe Tubau; Cristina Rodríguez; Bartolomé Moyà; Carmen Peña; Luis Martínez-Martínez; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2012-10-08       Impact factor: 5.191

Review 8.  Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation β-Lactam/β-Lactamase Inhibitor Combinations.

Authors:  David van Duin; Robert A Bonomo
Journal:  Clin Infect Dis       Date:  2016-04-20       Impact factor: 9.079

9.  Metallo-beta-lactamase-producing Pseudomonas putida as a reservoir of multidrug resistance elements that can be transferred to successful Pseudomonas aeruginosa clones.

Authors:  Carlos Juan; Laura Zamorano; Ana Mena; Sebastián Albertí; Jose Luis Pérez; Antonio Oliver
Journal:  J Antimicrob Chemother       Date:  2010-01-12       Impact factor: 5.790

10.  Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: Clinical Effectiveness and Evolution of Resistance.

Authors:  Ghady Haidar; Nathan J Philips; Ryan K Shields; Daniel Snyder; Shaoji Cheng; Brian A Potoski; Yohei Doi; Binghua Hao; Ellen G Press; Vaughn S Cooper; Cornelius J Clancy; M Hong Nguyen
Journal:  Clin Infect Dis       Date:  2017-07-01       Impact factor: 9.079
View more
  2 in total

Review 1.  Resistance to Novel β-Lactam-β-Lactamase Inhibitor Combinations: The "Price of Progress".

Authors:  Krisztina M Papp-Wallace; Andrew R Mack; Magdalena A Taracila; Robert A Bonomo
Journal:  Infect Dis Clin North Am       Date:  2020-09-30       Impact factor: 5.982

Review 2.  β-lactam Resistance in Pseudomonas aeruginosa: Current Status, Future Prospects.

Authors:  Karl A Glen; Iain L Lamont
Journal:  Pathogens       Date:  2021-12-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.